These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 38751959)

  • 21. 5-Year Outcomes After Left Atrial Appendage Closure: From the PREVAIL and PROTECT AF Trials.
    Reddy VY; Doshi SK; Kar S; Gibson DN; Price MJ; Huber K; Horton RP; Buchbinder M; Neuzil P; Gordon NT; Holmes DR;
    J Am Coll Cardiol; 2017 Dec; 70(24):2964-2975. PubMed ID: 29103847
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cryoballoon pulmonary vein ablation and left atrial appendage closure combined procedure: A long-term follow-up analysis.
    Fassini G; Gasperetti A; Italiano G; Riva S; Moltrasio M; Dello Russo A; Casella M; Maltagliati A; Tundo F; Majocchi B; Arioli L; Al-Mohani G; Pontone G; Pepi M; Tondo C
    Heart Rhythm; 2019 Sep; 16(9):1320-1326. PubMed ID: 30928784
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Combined catheter ablation and left atrial appendage closure as a hybrid procedure for the treatment of atrial fibrillation.
    Calvo N; Salterain N; Arguedas H; Macias A; Esteban A; García de Yébenes M; Gavira JJ; Barba J; García-Bolao I
    Europace; 2015 Oct; 17(10):1533-40. PubMed ID: 25935163
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Sex Differences in the Combined Ablation and Left Atrial Appendage Closure: Results From LAACablation Registry.
    Chen M; Sun J; Li W; Zhang PP; Zhang R; Mo BF; Yang M; Wang QS; Li YG
    JACC Asia; 2023 Feb; 3(1):138-149. PubMed ID: 36873751
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Combining left atrial appendage closure and catheter ablation for atrial fibrillation: 2-year outcomes from a multinational registry.
    Phillips KP; Romanov A; Artemenko S; Folkeringa RJ; Szili-Torok T; Senatore G; Stein KM; Razali O; Gordon N; Boersma LVA
    Europace; 2020 Feb; 22(2):225-231. PubMed ID: 31665276
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Long-term outcomes of left atrial appendage closure with or without concomitant pulmonary vein isolation:a propensity score matching analysis based on CLACBAC study.
    Li X; Feng S; Ren Z; Wu J; Zhou L; Yang H; Zheng Y; Meng W; Zhang J; Su Y; Jiang Y; Xu J; Sun H; Xu Y; Zhao D; Yin X
    BMC Cardiovasc Disord; 2024 Feb; 24(1):85. PubMed ID: 38310248
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Feasibility and perioperative safety of the combined procedure of catheter ablation and watchman left atrial appendage closure].
    Wang QS; Chen M; Sun J; Zhang PP; Li W; Mo BF; Yu Y; Feng XF; Lu QF; Li YG
    Zhonghua Xin Xue Guan Bing Za Zhi; 2020 Oct; 48(10):842-847. PubMed ID: 33076621
    [No Abstract]   [Full Text] [Related]  

  • 28. Catheter ablation in combination with left atrial appendage closure for atrial fibrillation.
    Swaans MJ; Alipour A; Rensing BJ; Post MC; Boersma LV
    J Vis Exp; 2013 Feb; (72):e3818. PubMed ID: 23486416
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Catheter Ablation for Atrial Fibrillation in Patients With Watchman Left Atrial Appendage Occlusion Device: Results from a Multicenter Registry.
    Turagam MK; Lavu M; Afzal MR; Vuddanda V; Jazayeri MA; Parikh V; Atkins D; Bommana S; DI Biase L; Horton R; Bai R; Swarup V; Cheng J; Natale A; Lakkireddy D
    J Cardiovasc Electrophysiol; 2017 Feb; 28(2):139-146. PubMed ID: 27943538
    [TBL] [Abstract][Full Text] [Related]  

  • 30. One-stop strategy for treatment of atrial fibrillation: feasibility and safety of combining catheter ablation and left atrial appendage closure in a single procedure.
    Chen M; Wang ZQ; Wang QS; Sun J; Zhang PP; Feng XF; Li W; Yu Y; Liu B; Mo BF; Zhang R; Yang M; Gong CQ; Zhao MZ; Yu YC; Zhao Y; Lu QF; Li YG
    Chin Med J (Engl); 2020 Jun; 133(12):1422-1428. PubMed ID: 32433041
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Combination of left atrial appendage closure and catheter ablation in a single procedure for patients with atrial fibrillation: Multicenter experience.
    Du X; Chu H; Ye P; He B; Xu H; Jiang S; Lin M; Lin R; Liu J; Wang B; Feng M; Yu Y; Chen X
    J Formos Med Assoc; 2019 May; 118(5):891-897. PubMed ID: 30482569
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cost-Effectiveness of Left Atrial Appendage Closure for Stroke Reduction in Atrial Fibrillation: Analysis of Pooled, 5-Year, Long-Term Data.
    Reddy VY; Akehurst RL; Gavaghan MB; Amorosi SL; Holmes DR
    J Am Heart Assoc; 2019 Jul; 8(13):e011577. PubMed ID: 31230500
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Feasibility and Safety of Left Atrial Appendage Closure Using the LAmbre Device in Patients with Nonvalvular Atrial Fibrillation with or Without Prior Catheter Ablation.
    Feng XF; Zhang PP; Sun J; Wang QS; Li YG
    Int Heart J; 2019 Jan; 60(1):63-70. PubMed ID: 30464131
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Direct current cardioversion practices following percutaneous left atrial appendage closure.
    Bhuta S; Shaaban A; Binda NC; Antaki J; Augostini RS; Kalbfleisch SJ; Savona SJ; Okabe T; Houmsse M; Afzal MR; Daoud EG; Hummel JD
    J Cardiovasc Electrophysiol; 2023 Aug; 34(8):1698-1705. PubMed ID: 37493499
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The WATCHMAN left atrial appendage closure device for patients with atrial fibrillation: current status and future perspectives.
    Wintgens LIS; Maarse M; Swaans MJ; Rensing BJWM; Van Dijk VF; Boersma LVA
    Expert Rev Med Devices; 2020 Jul; 17(7):615-626. PubMed ID: 32543911
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Iatrogenic Atrial Septal Defect after Intracardiac Echocardiography-Guided Left Atrial Appendage Closure: Incidence, Size, and Clinical Outcomes.
    Ma Y; Guo L; Li J; Liu H; Xu J; Du H; Wang Y; Li H; Yi F
    J Clin Med; 2022 Dec; 12(1):. PubMed ID: 36614961
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Thromboembolism after electrical isolation of the left atrial appendage: a new indication for interventional closure?
    Zender N; Weise FK; Bordignon S; Herrmann E; Konstantinou A; Bologna F; Nagase T; Chen S; Chun KRJ; Schmidt B
    Europace; 2019 Oct; 21(10):1502-1508. PubMed ID: 31230078
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Transition from WATCHMAN generation-2.5 device to WATCHMAN FLX device for percutaneous left atrial appendage closure: Incidence and predictors of device-related thrombosis and short- to mid-term outcomes.
    Chatani R; Kubo S; Tasaka H; Nishiura N; Mushiake K; Ono S; Maruo T; Kadota K
    Catheter Cardiovasc Interv; 2024 Jun; ():. PubMed ID: 38895767
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Watchman FLX vs. Watchman 2.5 in a Dual-Center Left Atrial Appendage Closure Cohort: the WATCH-DUAL study.
    Galea R; Mahmoudi K; Gräni C; Elhadad S; Huber AT; Heg D; Siontis GCM; Brugger N; Sebag F; Windecker S; Valgimigli M; Landolff Q; Roten L; Amabile N; Räber L
    Europace; 2022 Oct; 24(9):1441-1450. PubMed ID: 35253840
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Feasibility and clinical efficacy of left atrial ablation for the treatment of atrial tachyarrhythmias in patients with left atrial appendage closure devices.
    Heeger CH; Rillig A; Lin T; Mathew S; Deiss S; Lemes C; Botros M; Metzner A; Wissner E; Kuck KH; Ouyang F; Tilz RR
    Heart Rhythm; 2015 Jul; 12(7):1524-31. PubMed ID: 25769512
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.